It's an open forum for Indian Clinical and Hospital Pharmacists to discuss on designing, implementing, and monitoring a therapeutic plan that will produce specific therapeutic outcomes for the patient Eg:Antibiotic Policies, Pharmacist Interventions, Medication Therapy Management. DRP,s and Its Management.
Forum rules: Dear User, Kindly read our forum rules before you proceed with our PharmD Info, Your first 5 posts/topics requires moderator approval and this website is purely meant for educational and knowledge sharing purpose only so you should not make any topics/replies/messages which criticize, threaten or abuse any member, pharmacy governing bodies and organizations. Your post will be deleted automatically by our BB Pruning System if your topic is not viewed by members for more than 5 days. So, make sure that your topics and its related contents are unique and valuable. We expect you to be an active member of our forum to continue with your free membership.Kindly note that if a member received more than five warnings from moderator/members they will be blocked automatically by our Bulletin Board system.
The following drug profiles contain data which have been compiled from various reference sources and the clinical experience of the contributors.
“Usual dosages” reflect those considered most likely to achieve the desired serum concentrations, in patients with normal renal and hepatic function. When variable dosages are recommended for different patient groups, these have been represented diagrammatically.
Other parameters such as the usual dosing interval, time-to-peak concentration, time to steady-state serum concentration, elimination half-life, and protein binding are described for patients with normal organ function and average pharmacokinetic characteristics.
The therapeutic ranges quoted provide guidelines as to the patient drug concentrations which are expected to achieve optimal therapeutic effect. These therapeutic ranges are visualized as a green shaded area on the therapeutic range diagram lying between the subtherapeutic (blue) concentration and the potentially toxic (red) drug concentration.
Only a partial list of toxic effects and factors affecting drug concentrations are provided. These lists are not intended to be comprehensive. For more detailed information on individual drug preparations and characteristics, the manufacturer’s package insert and the current medical literature should be consulted.